(Press-News.org) Study Title: RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Publication: Journal of Clinical Oncology
Dana-Farber Cancer Institute author: Patrick Y. Wen, MD
Summary: In order to accurately assess the efficacy of novel therapies for brain tumors it is necessary to have reliable criteria to determine response or progression. Response assessment in brain tumors is difficult because of the irregular shapes of the tumors and the fact that many therapies used to treat these tumors can also produce imaging changes that resemble tumor growth. Neuro-oncologists currently use guidelines, defined by the Response Assessment in Neuro-Oncology (RANO) working (RANO criteria) led by Dana-Farber, to determine response to therapies in glioma patients during clinical trials. Over time several sets of RANO criteria have been developed to evaluate novel therapies such as immunotherapies.
This paper recommends an update to the RANO criteria (RANO 2.0), based on the results of a study conducted by Dana-Farber which defines a single set of criteria for all glioma cases. RANO 2.0, proposed by Dana-Farber Cancer Institute neuro-oncologist Patrick Y. Wen, MD, Director of the Center for Neuro-Oncology, and an international team of neuro-oncologists and neuroradiologists in the RANO Working Group, should be used for both high- and low-grade gliomas and for all glioma trials, regardless of the type of therapy being investigated. There is guidance on distinguishing the effects of treatment with immunotherapy or radiochemotherapy from tumor progression and separate criteria for these treatment modalities are no longer needed.
Impact: Glioblastomas and other gliomas are the most common type of malignant primary brain tumor, yet few effective therapies are available. Over ten years ago, researchers created the RANO criteria to accelerate the discovery of new medicines by improving the reliability of clinical trial results and making it possible for investigators to compare the results of one trial to another. RANO 2.0 is an important update that provides one single set of criteria for investigators to use for clinical research in glioma. It will reduce confusion about which criteria to use in each trial and will also improve reliability and comparability of trial data, and hopefully help accelerate the development of more effective therapies for patients with brain tumors.
Contact: Nicole Oliverio, nicole_oliverio@dfci.harvard.edu, 617-257-0454
END
New criteria to assess progression in glioma aims to speed discovery of new medicines
2023-09-29
ELSE PRESS RELEASES FROM THIS DATE:
NPS team makes key breakthrough on path to electric aircraft propulsion
2023-09-29
As an institution renowned for innovation efforts grounded in education and research, the Naval Postgraduate School (NPS) has often been called upon to tackle some of the most difficult technological challenges facing the Navy and the nation.
Such a challenge emerged in 2020, when NASA charged NPS and two other research teams with solving a critical barrier facing the development of electric aircraft propulsion (EAP): the creation of a circuit breaker that could support large electric platforms running on direct current (DC) electricity. Thanks to the efforts of a diverse team of faculty and students, as well as several Navy and academic research partners, NPS delivered ...
Berkeley Lab awarded two new centers to counter climate change
2023-09-29
The Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) will host two new centers dedicated to advancing clean energy technology and combating climate change. The awards are part of DOE’s Energy Earthshots Initiative that launched in 2021 with the goal of speeding up technological breakthroughs and lowering costs.
DOE has so far launched seven Earthshots spanning clean energy and carbon reduction technologies. The Berkeley Lab programs announced today will address two of them: the Hydrogen ...
Stanford researchers unveil new material infused with gold in an exotic chemical state
2023-09-29
For the first time, Stanford researchers have found a way to create and stabilize an extremely rare form of gold that has lost two negatively charged electrons, denoted Au2+. The material stabilizing this elusive version of the valued element is a halide perovskite—a class of crystalline materials that holds great promise for various applications including more-efficient solar cells, light sources, and electronics components.
Surprisingly, the Au2+ perovskite is also quick and simple to make using off-the-shelf ingredients at room temperature.
"It was a real surprise that we were able to synthesize a stable material containing Au2+—I didn't even believe it at ...
Research Highlights for September 2023
2023-09-29
Huntsman Cancer Institute shines the spotlight on new discoveries and cutting-edge cancer research. This month, researchers found that increasing access for Black people with prostate cancer may save lives. Also, the first patient in a new small cell lung cancer clinical trial has been enrolled, researchers are using an app to help adolescents and young adults manage cancer symptoms, and investigators are trying to reduce cognitive side-effects after chemotherapy.
Increasing access to Black people with prostate cancer may decrease mortality rate
In a study published ...
JMIR Publications places No, 348 on The Globe and Mail's annual ranking of Canada's Top Growing Companies
2023-09-29
(Toronto, September 29, 2023) JMIR Publications is pleased to announce it placed No. 348 on the 2023 Report on Business ranking of Canada’s Top Growing Companies, making the ranking over the past three consecutive years.
Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. JMIR Publications earned its spot with three-year growth of 105%.
“Being ranked on this list, year over year, showcases JMIR Publications’ national and global leadership in publishing high-quality open access ...
Argonne National Laboratory launches South Side STEM Opportunity Landscape Project at DuSable Black History Museum and Education Center
2023-09-29
A transformative initiative aimed at identifying, enhancing and promoting science, technology, engineering and mathematics resources within local communities.
The U.S. Department of Energy’s Argonne National Laboratory is proud to announce the official launch of the South Side STEM Opportunity Landscape Project, a transformative initiative aimed at identifying, enhancing and promoting science, technology, engineering and mathematics (STEM) resources within local communities.
As part of the Argonne in Chicago initiative that includes offices in Hyde Park, the ...
Allergy study on 'wild' mice challenges the hygiene hypothesis
2023-09-29
The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis. Now, an article published in Science Immunology by researchers from Karolinska Institutet challenges this hypothesis by showing that mice with high infectious exposures from birth have the same, if not an even greater ability to develop allergic immune responses than 'clean' laboratory mice.
How microbes may prevent allergy has been a topic of great interest in recent times. Studies have suggested that certain infections might reduce the production of inflammatory antibodies to ...
Ancient plant wax reveals how global warming affects methane in Arctic lakes
2023-09-29
New study makes novel use of plant biomarkers preserved in sediment to reconstruct methane cycling over the past 10,000 years
Plant waxes hold an isotopic signature of ancient methane
As planet warmed due to slow changes in Earth’s orbit, lakes produced increased amounts of methane, which is a potent greenhouse gas
Researcher: ‘Living on a warming planet, we can look to these signs from the past to predict our future’
EVANSTON, Ill. — By studying fossils from ancient aquatic plants, ...
Atopic dermatitis: Viruses discovered as new therapy option
2023-09-29
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great distress to the patients. In the course of a study conducted at MedUni Wien a research team led by Wolfgang Weninger, Head of the Department of Dermatology, has discovered a new approach: bacteriophages, which colonize the skin as viral components of the microbiome and can drive the development of innovative ...
Larger lymph node threshold optimizes nasopharyngeal carcinoma outcomes
2023-09-29
Leesburg, VA, September 29, 2023—According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma (NPC).
“Future American Joint Committee on Cancer (AJCC) staging updates should consider incorporation of the 6-mm threshold for N-category and tumor-stage determinations,” wrote corresponding author Zhiying Liang, MD, from the radiology department at China’s Sun Yat-sen University Cancer Center.
This AJR accepted manuscript by Liang et al. included ...